Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017438 220008070 1.65 74 Curative (C) 2013-07-01 2013-07-01 Triple Intrathecal N N 220030735 TRIPLE INTRATHECAL
220017439 220008071 0 93 Curative (C) 2017-02-06 2017-02-07 ATG + Busulfan + Fludarabine N null 220030736 ATG + BUSULFAN + FLUDARABINE
220017440 220008072 1.25 69 Disease modification (D) 2011-04-16 2014-10-23 ATG + Busulfan + Fludarabine N N 220030737 ATG + BUSULFAN + FLUDARABINE
220017441 220008074 1.71 50.5 Curative (C) 2017-04-01 2017-04-01 FLAG N N 220030739 FLAG
220017442 220008077 1.28 113.8 null 2014-08-03 2014-08-03 Methotrexate intrathecal 02 N 220030743 METHOTREXATE INTRATHECAL
220017443 220008082 1.64 71.45 Curative (C) 2014-08-29 2014-10-21 Triple / Double Intrathecal Therapy N N 220030754 TRIPLE INTRATHECAL
220017444 220008087 null 80.8 Palliative (P) 2014-08-04 2014-08-06 AML16 DA 3+10 N N 220030766 AML16 TRIAL
220017445 220008089 null 60.9 Curative (C) null 2016-10-13 BOSUTINIB N N 220030766 BOSUTINIB
220017447 220020925 null 80.3 Palliative (P) 2017-08-21 2017-08-21 Triple Intrathecal 02 N 220030783 TRIPLE INTRATHECAL
220017448 220008094 1.73 100.3 Palliative (P) 2013-12-05 2014-09-24 AML Int Guide ADE 10+3+5 (1) N N 220030802 ADE
220017449 220008094 1.68 56 Disease modification (D) 2015-10-01 2015-10-01 Triple / Double Intrathecal Therapy N N 220030802 TRIPLE INTRATHECAL
220017451 220008100 1.67 155 Curative (C) 2017-04-04 2017-04-04 AML16 DA 3+10 02 N 220030811 AML16 TRIAL
220017452 220017872 0 43.4 Curative (C) 2013-08-24 2013-08-27 Cyclophosphamide+Fludara+TBI Allo N N 220030823 CYCLOPHOSPHAMIDE + FLUDARABINE
220017453 220008103 null 56.7 Curative (C) 2014-05-11 2014-06-15 IDARUBICIN + TRETINOIN null null 220030837 IDARUBICIN + TRETINOIN
220017454 220008105 1.67 59.3 Disease modification (D) 2016-06-27 2016-06-27 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220030840 CYCLOPHOSPHAMIDE + FLUDARABINE
220017455 220008109 1.78 74.5 Curative (C) 2013-09-26 2013-09-27 BOSUTINIB 02 N 220030849 BOSUTINIB
220017456 220014426 1.8 85.2 Disease modification (D) 2016-09-23 2017-12-01 ATG + Busulfan + Fludarabine 02 Y 220030858 ATG + BUSULFAN + FLUDARABINE
220017457 220008112 1.86 68.8 null 2017-07-17 2017-07-17 FLAG 02 N 220030863 FLAG
220017458 220008112 null 9.2 Curative (C) 2016-07-29 2016-09-21 AML Int Guide ADE 10+3+5 (1) 02 N 220030863 ADE
220017459 220008115 null null Disease modification (D) 2014-05-02 2018-01-18 BOSUTINIB N null 220030873 BOSUTINIB
220017461 220008120 1.64 null null 2013-08-13 2013-12-04 Idarubicin+Tretinoin Spanish Crse2 N N 220030896 IDARUBICIN + TRETINOIN
220017463 220008126 null 104.2 Palliative (P) 2017-01-17 2017-07-08 IDARUBICIN + TRETINOIN 99 N 220030906 IDARUBICIN + TRETINOIN
220017464 220008128 null 65 Curative (C) 2016-07-11 2017-03-06 FLAG 02 null 220030913 FLAG
220017465 220008131 null 99.7 Curative (C) 2014-02-07 2014-02-08 FLAG N N 220030919 FLAG
220017466 220008134 1.83 60 Curative (C) 2014-01-24 2014-01-24 IDARUBICIN + TRETINOIN 02 N 220030929 IDARUBICIN + TRETINOIN
220017467 220008135 1.67 78.5 Curative (C) 2017-07-18 2017-07-19 Triple Intrathecal 2 N 220030936 TRIPLE INTRATHECAL
220017468 220008137 1.62 65 Curative (C) 2017-08-06 2017-08-06 CYCLOPHOSPHAMIDE N N 220030939 CYCLOPHOSPHAMIDE
220017469 220008138 null null Curative (C) 2014-05-30 2014-06-05 FLAG 02 N 220030945 FLAG
220017470 220008139 null null Palliative (P) 2015-03-12 2015-03-15 RUXOLITINIB N N 220030950 RUXOLITINIB
220017471 220008142 null 38 Curative (C) 2018-08-19 2018-08-19 Triple Intrathecal N N 220030955 TRIPLE INTRATHECAL
220017473 220008152 null 80.1 Disease modification (D) 2013-11-12 2013-11-14 Triple Intrathecal 02 N 220030962 TRIPLE INTRATHECAL
220017474 220017886 1.65 14 Not known (9) 2014-08-08 2014-08-10 FLAG N Y 220030966 FLAG
220017475 220008158 0 60 Palliative (P) 2014-03-12 2014-03-18 ATG + Busulfan + Fludarabine 02 N 220030971 ATG + BUSULFAN + FLUDARABINE
220017476 220014453 null 68.8 Curative (C) 2016-05-10 2016-05-10 IDARUBICIN + TRETINOIN N N 220030973 IDARUBICIN + TRETINOIN
220017477 220008161 1.75 87.3 Curative (C) 2018-05-25 2018-05-25 Triple Intrathecal N N 220030983 TRIPLE INTRATHECAL
220017478 220008162 0 102 Curative (C) 2014-08-26 2014-08-26 Cyclophosphamide+Fludara+TBI Allo 02 N 220030983 CYCLOPHOSPHAMIDE + FLUDARABINE
220017479 220008164 1.9 80.7 Disease modification (D) null 2018-11-08 AML Int Guide ADE 10+3+5 (1) 99 N 220030991 ADE
220017481 220008167 null 59.3 Curative (C) null 2013-05-31 Cyclophosphamide oral N N 220031002 CYCLOPHOSPHAMIDE
220017482 220014458 1.77 null Palliative (P) 2019-03-01 2019-03-01 BOSUTINIB Y N 220031003 BOSUTINIB
220017483 220019818 1.7 null Palliative (P) 2018-01-25 2018-02-12 Triple Intrathecal N N 220031027 TRIPLE INTRATHECAL
220017484 220021898 null 8.3 Curative (C) 2016-03-22 2016-08-07 CYCLOPHOSPHAMIDE + FLUDARABINE null null 220031038 CYCLOPHOSPHAMIDE + FLUDARABINE
220017485 220008177 1.51 79.8 Adjuvant (A) 2014-10-26 2014-10-26 RUXOLITINIB 02 N 220031045 RUXOLITINIB
220017486 220008179 1.7 null Disease modification (D) 2015-12-29 2016-01-10 BOSUTINIB 2 N 220031046 BOSUTINIB
220017487 220020930 1.71 null Curative (C) 2017-11-29 2017-12-03 Cyclophosphamide TBI Allograft N N 220031047 CYCLOPHOSPHAMIDE
220017488 220008182 1.58 56.7 Curative (C) 2018-01-30 2018-01-30 CYCLOPHOSPHAMIDE + FLUDARABINE 02 N 220031049 CYCLOPHOSPHAMIDE + FLUDARABINE
220017489 220014464 null 83.1 null null 2015-01-03 FLAG null N 220031051 FLAG
220017490 220014464 1.93 87.8 Curative (C) 2017-08-27 2017-08-27 BOSUTINIB 2 null 220031051 BOSUTINIB
220017491 220008185 0 9.2 Disease modification (D) 2018-02-15 2018-04-02 RUXOLITINIB 2 N 220031065 RUXOLITINIB
220017492 220008187 null 78.6 Palliative (P) null 2014-06-15 Idarubicin+Tretinoin Spanish Crse2 N N 220031084 IDARUBICIN + TRETINOIN
220017493 220008188 1.67 54.6 Curative (C) 2018-12-18 2018-12-18 FLAG N N 220031093 FLAG